Strategy Consulting & Institutional Market Intelligence

In most engagements, the distinction between strategy and investment research is artificial.
A capital raise may require a financial model and investor materials from the Investment Research practice, together with commercial strategy and positioning from this practice. A market entry or acquisition may require commercial due diligence, market intelligence, valuation, and financial modelling across both. We operate these capabilities as one function, ensuring that the strategy, narrative, and financial model are built on the same underlying assumptions.

Standard market research usually answers the question the client asked. Commercial due diligence is designed to uncover the question the client may not yet know to ask. Market research maps and quantifies the opportunity. Commercial due diligence tests the assumptions, challenges the management case, and identifies the risks that could change the decision. The scope develops with the evidence rather than remaining limited to the original question.

Our client work spans the US, UK and Europe, GCC, and India, supported by direct engagement experience across each market. Cross-border mandates require the macroeconomic, regulatory, and competitive context of each geography to be considered from the outset. Demand patterns, customer behaviour, and competitive intensity can vary materially between markets, and the strategy must reflect those differences.

Our deepest experience is in life sciences, biotechnology, clean technology, and technology - sectors where regulatory pathways, non-standard commercial models, and rapidly changing competitive dynamics require genuine domain expertise. We also have significant experience across BFSI, fintech and digital assets, consumer, manufacturing, and smart logistics and fulfilment in the US, GCC, and Indian markets.

Usually at one of three moments.
The decision is difficult to reverse and the cost of being wrong is high - such as a market entry, acquisition, or strategic pivot. The internal team is too close to the issue to assess it objectively. Or the intelligence required to make the decision does not exist in-house and cannot be developed within the available timeline. When none of these conditions applies, the internal team may be the better option - and we will say so.

Most of our clients already have one. We take on the evidence-gathering that consumes the most time, including field interviews, competitor benchmarking, channel research, and demand assessment. This allows the internal team to focus on judgement, alignment, and execution. The strategic direction remains with the client; we provide the research and analysis that strengthen it.

A published report answers the question its author chose to examine, based on the information available when it was written. Our work is designed around the specific decision in front of the client. The assumptions remain traceable and open to challenge, while primary research tests whether the published view still reflects current commercial reality. When an off-the-shelf report is sufficient, we will recommend using it.

Start with the decision, not the service line. Most mandates begin in one practice and extend into another. A market entry may require feasibility assessment and a go-to-market plan. A capital raise may require investor readiness, financial modelling, and a positioning narrative.
Tell us the decision you are facing, and we will map it to the relevant practices and scope only the work that contributes to the outcome.

Pricing depends on the scope, engagement type, depth of work, number of geographies involved, and whether the mandate is a fixed project or an ongoing retainer. A single-market feasibility assessment and a multi-geography transformation programme require very different levels of work. Once the mandate and timeline are clear, we define the scope and provide a complete quote before the engagement begins, with no open-ended billing.